Here’s what you should know:
1. Researchers believe the findings could help develop tumor-inhibiting treatments.
2. A small group of molecules, miR-371 to 373 cluster, regulates colon cancer metastasis.
3. Researchers observed the cluster in experimental and computational analyses. They found the cluster is deactivated in a specific population of aggressive, fast-growing cancer cells. After they reactivated the cluster, metastatic cell growth slowed significantly.
4. The researchers validated their results in patient samples from a large Luxembourgish colon cancer collection.
5. Lead study author Pit Ullmann, PhD, said, “Cancer is a really complex disease. While our results are just one piece of the puzzle, they clearly contribute to a better understanding of tumor initiation and metastasis and might be an important first step for the development of novel therapeutic strategies.”
More articles on gastroenterology:
ASC supply chain tip of the day: Copy what works at hospitals
Outpatient arthroplasty patients would choose to undergo surgery again: 4 study facts
5 key facts about The Joint Commission’s accreditation and certification decisions
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
